SCHEMBL6947571

SCHEMBL6947571

Cc1nc(OC(F)(F)C(F)F)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.40
ALDH1A1 P00352 8/20 0.40
HTT P42858 4/20 0.40
HSD17B10 Q99714 4/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
HPGD P15428 4/20 0.40
MAPT P10636 4/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 2/20 0.39
NPC1 O15118 1/20 0.38
POLB P06746 3/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CXCR4 P61073 1/20 0.35
NPY5R Q15761 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PLK1 P53350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950038 0.85 KDM4E (0.41) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6952290 0.85 KDM4E (0.39) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6956303 0.83 KDM4E (0.41) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6952068 0.83 ALDH1A1 (0.49) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6957783 0.80 HRH4 (0.44) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6951193 0.79 ALDH1A1 (0.41) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6948352 0.78 ALDH1A1 (0.46) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6953934 0.78 KDM4E (0.43) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6947782 0.77 CXCR4 (0.41) KDM4EALDH1A1HTTHSD17B10MEN1
SCHEMBL6947498 0.77 CXCR4 (0.43) KDM4EALDH1A1HTTHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed